search
Back to results

The Innovation of 3D Printing for Preoperative Planning in Hip Preservation Surgery

Primary Purpose

Femoro Acetabular Impingement

Status
Enrolling by invitation
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
3D Print + Conventional imaging
Conventional imaging
Sponsored by
Nova Scotia Health Authority
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Femoro Acetabular Impingement focused on measuring Femoroacetabular Impingement, Cam lesion, 3D printing, Pre-operative planning

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Radiological proven diagnosis of cam-type femoroacetabular impingement (FAI)

Exclusion Criteria:

  • Patients with advanced arthritis (Tonnis Grade III or Kellgren-Lawrence Grade III or IV or evidence of less than 2 mm of joint space, as determined by conventional radiographs.)
  • Patients with 1cm2 (or greater) of cartilage delamination in the hip
  • Patients with type III or IV heterotopic ossification
  • Patients with avascular necrosis
  • Patients who are unable to provide informed consent
  • Patients who are undergoing revision hip arthroscopy
  • Patients who are pregnant
  • Patients who have the presence of local or systemic infection
  • Patients with an inability to cooperate with and/or comprehend post-operative instructions
  • Patients with nonvascular surgical sites (MRI proven)
  • Patients with cancer

Sites / Locations

  • 5955 Veterans' Memorial Lane Room 2106, VMB

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

3D Print + Conventional imaging

Conventional Imaging

Arm Description

Patients in this group allocation will receive a 3D reconstruction of their hip in addition to conventional preoperative imaging (X-ray, CT, and MRI) only for the use of pre-operative and intra-operative planning for their hip arthroscopy (FAI) procedure.

Patients in this group allocation will receive conventional preoperative imaging (X-ray, CT, and MRI) only for the use of pre-operative and intra-operative planning for their hip arthroscopy (FAI) procedure.

Outcomes

Primary Outcome Measures

Measure of CAM resection
Our primary outcome for this study is the resection of cam impingement according to alpha-angle on post-operative anterior-posterior (AP) and frog leg X-ray views.
Measure of CAM resection
Our primary outcome for this study is the resection of cam impingement according to alpha-angle on post-operative anterior-posterior (AP) and frog leg X-ray views.
Measure of CAM resection
Our primary outcome for this study is the resection of cam impingement according to alpha-angle on post-operative anterior-posterior (AP) and frog leg X-ray views.

Secondary Outcome Measures

Differences in post-operative patient reported outcomes: iHOT-33
The secondary outcome is the differences in post-operative patient reported outcomes for the international hip outcome tool (iHOT-33) when compared to a pre-operative baseline. (Scores for the International hip outcome tool range from 0-100 where higher values represent better outcomes)
Differences in post-operative patient reported outcomes: NAHS
The secondary outcome is the differences in post-operative patient reported outcomes for the Non-arthritic Hip Score (NAHS) when compared to a pre-operative baseline. (Scores for the Non-arthritic Hip Score range from 0-80 where higher values represent better outcomes).
Differences in post-operative patient reported outcomes: EQ5D
The secondary outcome is the differences in post-operative patient reported outcomes for the European Quality of Life Questionnaire (EQ-5D) when compared to a pre-operative baseline. (Scores for EQ-5D range from 1-5 in 5 categories where lower values represent better outcomes in each category).
Differences in post-operative patient reported outcomes: EQ5D-VAS
The secondary outcome is the differences in post-operative patient reported outcomes for the European Quality of Life Questionnaire-Visual Analog Scale (EQ-5D-VAS) when compared to a pre-operative baseline. (Scores for EQ-5D-VAS range from 0-100 where higher values represent better outcomes).
Differences in post-operative patient reported outcomes: VR-12
The secondary outcome is the differences in post-operative patient reported outcomes for the Veteran's RAND 12 Item Health Survey (VR-12) when compared to a pre-operative baseline. (Scores for VR-12 range from 0-100 where higher values represent better outcomes).
Differences in post-operative patient reported outcomes: HOS-Usual Activities
The secondary outcome is the differences in post-operative patient reported outcomes for the Hip Outcome Score for usual activities (HOS-UA) when compared to a pre-operative baseline. (Scores for HOS range from 0-68 where higher values represent better outcomes).
Differences in post-operative patient reported outcomes: HOS-Sport
The secondary outcome is the differences in post-operative patient reported outcomes for the Hip Outcome Score for sports (HOS-S) when compared to a pre-operative baseline. (Scores for HOS range from 0-30 where higher values represent better outcomes).

Full Information

First Posted
April 30, 2020
Last Updated
September 5, 2023
Sponsor
Nova Scotia Health Authority
search

1. Study Identification

Unique Protocol Identification Number
NCT04505020
Brief Title
The Innovation of 3D Printing for Preoperative Planning in Hip Preservation Surgery
Official Title
The Innovation of 3D Printing for Preoperative Planning in Hip Preservation Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
January 1, 2021 (Actual)
Primary Completion Date
August 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nova Scotia Health Authority

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a randomized controlled trial (RCT) to evaluate the introduction of a 3D printed model into the pre and intra-operative planning for arthroscopic femoroacetabular impingement (FAI) surgery. The RCT will look to place patients into one of two treatment groups: 1) conventional preoperative imaging (X-ray, CT, and MRI) only and 2) those that have had a 3D printed model created in addition to the conventional imaging.
Detailed Description
In this study, we investigate the use of 3D models during pre and intra-operative planning could improve the success of hip arthroscopy and reduce the incidence of revision cases. By adding an adjunct to the common suite of pre-operative imaging modalities (X-ray, MRI and CT), we can change the surgeon's understanding of each patient's individual morphology with a tactile physical model. This study will compare the success of hip arthroscopy in patients with or without 3D printed models (in addition to traditional pre-operative imaging). This will be a single-center, blinded observer, randomized controlled trial of 80 patients performed at the Halifax Infirmary, Queen Elizabeth II Health Sciences Center in Halifax, Nova Scotia. Patients with cam-type FAI involved in the study will be approached by the surgeon, Dr. Ivan Wong, or a delegate regarding the study during a pre-operative visit. Following a detailed discussion of the risks/benefits/alternatives of this study, the patient will be provided with a copy of the informed consent to review, if they demonstrate an interest in the study. If the patient wishes to be enrolled in the study, the research team will obtain patient consent for the study according to the Division of Orthopaedic Surgery and Nova Scotia Health Authority (NSHA) institutional protocols. In the pre-operative period, there will be no additional time requirements for the participant, except for the informed consent process for the study. Routine X-ray radiographs, as well as a pre-operative MRI and CT scan, will be obtained for all subjects undergoing FAI surgery. The participants will not be exposed to any additional radiation. Subjects will complete a structured clinical examination conducted by a sports medicine fellowship-trained orthopaedic consultant. The patient will also complete pre-operative questionnaires. Patients that have consented to the study will be randomized into two groups with a 50% chance of being in either group. Randomization will be done with a computer random number generator. Both groups will undergo routine pre-operative imaging but one group will also have a 3D print made from the 3D CT reconstruction. All patient groups will undergo hip arthroscopy for the treatment of their FAI.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Femoro Acetabular Impingement
Keywords
Femoroacetabular Impingement, Cam lesion, 3D printing, Pre-operative planning

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients that have consented to the study will be randomized into four groups with a 50% chance of being in either group. The two treatment groups are 1) conventional preoperative imaging (X-ray, CT, and MRI) only 2) those that have had a 3D printed model created in addition to conventional imaging. There will be 40 patients in each group. Randomization will be done with a computer random number generator. Both groups will undergo routine pre-operative imaging but one group will also have a 3D print made from the 3D CT reconstruction. Both patient groups will undergo hip arthroscopy for treatment of their FAI.
Masking
ParticipantOutcomes Assessor
Masking Description
Participants will be blinded/masked to the treatment (if they do or don't receive a 3D printed model of their hip) they receive until the end of the study. Patients will still be aware of the details of their surgical treatment.
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
3D Print + Conventional imaging
Arm Type
Experimental
Arm Description
Patients in this group allocation will receive a 3D reconstruction of their hip in addition to conventional preoperative imaging (X-ray, CT, and MRI) only for the use of pre-operative and intra-operative planning for their hip arthroscopy (FAI) procedure.
Arm Title
Conventional Imaging
Arm Type
Other
Arm Description
Patients in this group allocation will receive conventional preoperative imaging (X-ray, CT, and MRI) only for the use of pre-operative and intra-operative planning for their hip arthroscopy (FAI) procedure.
Intervention Type
Other
Intervention Name(s)
3D Print + Conventional imaging
Intervention Description
This group will have a 3D reconstruction of their hip printed using a 3D printer so that the PI can use it in their pre and intra-operative planning along with traditional imaging.
Intervention Type
Other
Intervention Name(s)
Conventional imaging
Intervention Description
This group will have CT, MRI and X-Ray imaging completed so that the PI can use it in their pre and intra-operative planning.
Primary Outcome Measure Information:
Title
Measure of CAM resection
Description
Our primary outcome for this study is the resection of cam impingement according to alpha-angle on post-operative anterior-posterior (AP) and frog leg X-ray views.
Time Frame
Change in Pre-op measurements compared to 2 weeks post-operatively
Title
Measure of CAM resection
Description
Our primary outcome for this study is the resection of cam impingement according to alpha-angle on post-operative anterior-posterior (AP) and frog leg X-ray views.
Time Frame
Change in Pre-op measurements compared to 6 months post-operatively
Title
Measure of CAM resection
Description
Our primary outcome for this study is the resection of cam impingement according to alpha-angle on post-operative anterior-posterior (AP) and frog leg X-ray views.
Time Frame
Change in Pre-op measurements compared to 24 months post-operatively
Secondary Outcome Measure Information:
Title
Differences in post-operative patient reported outcomes: iHOT-33
Description
The secondary outcome is the differences in post-operative patient reported outcomes for the international hip outcome tool (iHOT-33) when compared to a pre-operative baseline. (Scores for the International hip outcome tool range from 0-100 where higher values represent better outcomes)
Time Frame
Change in outcomes 24 months post operatively compared to Pre-operatively
Title
Differences in post-operative patient reported outcomes: NAHS
Description
The secondary outcome is the differences in post-operative patient reported outcomes for the Non-arthritic Hip Score (NAHS) when compared to a pre-operative baseline. (Scores for the Non-arthritic Hip Score range from 0-80 where higher values represent better outcomes).
Time Frame
Change in outcomes 24 months post operatively compared to Pre-operatively
Title
Differences in post-operative patient reported outcomes: EQ5D
Description
The secondary outcome is the differences in post-operative patient reported outcomes for the European Quality of Life Questionnaire (EQ-5D) when compared to a pre-operative baseline. (Scores for EQ-5D range from 1-5 in 5 categories where lower values represent better outcomes in each category).
Time Frame
Change in outcomes 24 months post operatively compared to Pre-operatively
Title
Differences in post-operative patient reported outcomes: EQ5D-VAS
Description
The secondary outcome is the differences in post-operative patient reported outcomes for the European Quality of Life Questionnaire-Visual Analog Scale (EQ-5D-VAS) when compared to a pre-operative baseline. (Scores for EQ-5D-VAS range from 0-100 where higher values represent better outcomes).
Time Frame
Change in outcomes 24 months post operatively compared to Pre-operatively
Title
Differences in post-operative patient reported outcomes: VR-12
Description
The secondary outcome is the differences in post-operative patient reported outcomes for the Veteran's RAND 12 Item Health Survey (VR-12) when compared to a pre-operative baseline. (Scores for VR-12 range from 0-100 where higher values represent better outcomes).
Time Frame
Change in outcomes 24 months post operatively compared to Pre-operatively
Title
Differences in post-operative patient reported outcomes: HOS-Usual Activities
Description
The secondary outcome is the differences in post-operative patient reported outcomes for the Hip Outcome Score for usual activities (HOS-UA) when compared to a pre-operative baseline. (Scores for HOS range from 0-68 where higher values represent better outcomes).
Time Frame
Change in outcomes 24 months post operatively compared to Pre-operatively
Title
Differences in post-operative patient reported outcomes: HOS-Sport
Description
The secondary outcome is the differences in post-operative patient reported outcomes for the Hip Outcome Score for sports (HOS-S) when compared to a pre-operative baseline. (Scores for HOS range from 0-30 where higher values represent better outcomes).
Time Frame
Change in outcomes 24 months post operatively compared to Pre-operatively
Other Pre-specified Outcome Measures:
Title
The number of times conventional imaging and 3D prints are referenced intra-operatively.
Description
Another secondary outcome is the number of times each of the following are referenced intra-operatively: X-Rays, MRI, MRA, CT, CT with 3D reconstruction and 3D model of patient's hip. Additionally the number of X-Ray images taken intra-operatively will be recorded.
Time Frame
During surgery only

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Radiological proven diagnosis of cam-type femoroacetabular impingement (FAI) Exclusion Criteria: Patients with advanced arthritis (Tonnis Grade III or Kellgren-Lawrence Grade III or IV or evidence of less than 2 mm of joint space, as determined by conventional radiographs.) Patients with 1cm2 (or greater) of cartilage delamination in the hip Patients with type III or IV heterotopic ossification Patients with avascular necrosis Patients who are unable to provide informed consent Patients who are undergoing revision hip arthroscopy Patients who are pregnant Patients who have the presence of local or systemic infection Patients with an inability to cooperate with and/or comprehend post-operative instructions Patients with nonvascular surgical sites (MRI proven) Patients with cancer
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ivan Wong, Dr.
Organizational Affiliation
Nova Scotia Health Authority
Official's Role
Principal Investigator
Facility Information:
Facility Name
5955 Veterans' Memorial Lane Room 2106, VMB
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 2E1
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Individual participant data will not be shared with other researchers.

Learn more about this trial

The Innovation of 3D Printing for Preoperative Planning in Hip Preservation Surgery

We'll reach out to this number within 24 hrs